Tech Company Financing Transactions
Cardeas Pharma Funding Round
On 4/10/2015, Cardeas Pharma raised $3.5 million in Series B investment from private investors.
Transaction Overview
Company Name
Announced On
4/10/2015
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2025 1st Ave. 1200
Seattle, WA 98121
USA
Seattle, WA 98121
USA
Phone
Website
Email Address
Not Recorded
Overview
Cardeas Pharma specializes in early-phase development of inhaled antibiotics to treat respiratory infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bruce Montgomery
Chief Operating Officer
Melissa Yeager
Browse more venture capital transactions:
Prev: 4/10/2015: tenKsolar venture capital transaction
Next: 4/10/2015: Peloton Technology venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs